​XENCO MEDICAL IS NAMED THE MEDICAL DEVICE/DIAGNOSTICS COMPANY OF THE YEAR AT THE PRESTIGIOUS 2025 TRAILBLAZER AWARDS IN NEW YORK CITY

SAN DIEGO, Oct 9 (Bernama) -- Pioneering medical technology company Xenco Medical has been named the Medical Device/Diagnostics Company of the Year at the 2025 PM360 Trailblazer Awards, held at Gotham Hall in New York City on September 30th. Drawing together the world’s leading life sciences organizations each year, the Trailblazer Awards crown the most innovative and impactful organizations, leaders, and initiatives shaping the future of healthcare. Xenco Medical won the top honor as the Company of the Year in the Medical Device/Diagnostics category for its trailblazing development of biomimetic implants, regenerative biomaterials, and composite polymer surgical instruments with AI-driven software technologies that redefine the continuum of surgical care. “This year’s winners showcase exactly what sets our industry apart—bold ideas, breakthrough innovation, and real-world impact,” said Anna Stashower, CEO and Publisher of PM360. “Their work improves lives, advances care, and drives the kind of progress that truly matters.” The other winners at the coveted awards ceremony included Merck & Company, named Pharmaceutical/Biotech Company of the Year and Vertex Pharmaceuticals for Specialty Pharma/Biotech Company of the Year.

“We are profoundly honored to have been named the Company of the Year in the Medical Device/Diagnostics category at the 2025 Trailblazer Awards, and we look forward to continuing to translate the abounding promise of science into a transformative impact on the lives of countless patients,” said Jason Haider, Founder and CEO of Xenco Medical.